Publications by authors named "Jason H Williams"

Claim this Profile
A
An Evaluation of the Drug Interaction Potential of Encorafenib in Combination With Binimetinib Using the Inje Cocktail in Patients With Cancer.
Joseph Piscitelli, Micaela B Reddy, Lance Wollenberg, Laurence Del Frari, Jason Gong, Jason H Williams

Clin Pharmacol Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetics Analysis of Talazoparib and Enzalutamide Combination Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer.
Mark Hadigol, Jason H Williams, Haihong Shi, Derek Z Yang, Justin Hoffman

J Clin Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Two-Part Mixture Model for the Incidence and Time Course of Cytokine Release Syndrome After Elranatamab Dosing in Multiple Myeloma Patients.
Donald Irby, Jennifer Hibma, Mohamed Elmeliegy, Diane Wang, Erik Vandendries, Jason H Williams

Clin Pharmacol Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the effect of modafinil on the pharmacokinetics of encorafenib and binimetinib in patients with BRAF V600-mutant advanced solid tumors.
Joseph Piscitelli, Micaela B Reddy, Lance Wollenberg, Laurence Del Frari, Jason Gong, Jason H Williams

Cancer Chemother Pharmacol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration.
Joseph Piscitelli, Micaela B Reddy, Lance Wollenberg, Laurence Del Frari, Jason Gong, Jason H Williams

Clin Pharmacokinet· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications of Immunogenicity Testing for Therapeutic Monoclonal Antibodies: A Quantitative Pharmacology Framework.
Jason H Williams, Kai H Liao, Donghua Yin, Xu Meng

AAPS J· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Joint Disposition Properties and Comprehensive Pharmacokinetic Characterization of Antibody-Drug Conjugates.
Kai H Liao, Jason H Williams, Santhosh Palani, Donghua Yin, Xu Meng

AAPS J· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study of PF-06840003, an oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor in patients with recurrent malignant glioma.
David A Reardon, Annick Desjardins, Olivier Rixe, Timothy Cloughesy, Shilpa Alekar, Jason H Williams

Invest New Drugs· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model-Based Characterization of the Pharmacokinetics, Target Engagement Biomarkers, and Immunomodulatory Activity of PF-06342674, a Humanized mAb Against IL-7 Receptor-α, in Adults with Type 1 Diabetes.
Jason H Williams, Chandrasekhar Udata, Bishu J Ganguly, Samantha L Bucktrout, Tenshang Joh

AAPS J· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bosutinib versus Placebo for Autosomal Dominant Polycystic Kidney Disease.
Vladimir Tesar, Kazimierz Ciechanowski, York Pei, Irina Barash, Megan Shannon, Jason H Williams

J Am Soc Nephrol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Mechanism-Based Pharmacokinetic/Pharmacodynamic Model for Bococizumab, a Humanized Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, and Its Application in Early Clinical Development.
Chandrasekhar Udata, Pamela D Garzone, Barry Gumbiner, Tenshang Joh, Hong Liang, Jason H Williams

J Clin Pharmacol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative assessment of clinical response in patients with rheumatoid arthritis between PF-05280586, a proposed rituximab biosimilar, and rituximab.
Jason H Williams, Matthew M Hutmacher, Matthew L Zierhut, Jean-Claude Becker, Barry Gumbiner

Br J Clin Pharmacol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes and complications related to the management of Bosniak cystic renal lesions.
Andrew Dennis Smith, Brian C Allen, Rupan Sanyal, James Daniel Carson, Haowei Zhang, Jason Henry Williams

AJR Am J Roentgenol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of valproic acid in pediatric patients with epilepsy: considerations for dosing spinal muscular atrophy patients.
Jason H Williams, Bhuvaneswari Jayaraman, Kathryn J Swoboda, Jeffrey S Barrett

J Clin Pharmacol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oligonucleotide-mediated survival of motor neuron protein expression in CNS improves phenotype in a mouse model of spinal muscular atrophy.
Jason H Williams, Rebecca C Schray, Carlyn A Patterson, Semira O Ayitey, Melanie K Tallent

J Neurosci· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymersome delivery of siRNA and antisense oligonucleotides.
Younghoon Kim, Manorama Tewari, J David Pajerowski, Shenshen Cai, Shamik Sen, Jason H Williams

J Control Release· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functionalized PEG-PEI copolymers complexed to exon-skipping oligonucleotides improve dystrophin expression in mdx mice.
Shashank R Sirsi, Rebecca C Schray, Xiangying Guan, Nicole M Lykens, Jason H Williams

Hum Gene Ther· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PEG-PEI copolymers for oligonucleotide delivery to cells and tissues.
Gordon J Lutz, Shashank R Sirsi, Jason H Williams

Methods Mol Biol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanopolymers improve delivery of exon skipping oligonucleotides and concomitant dystrophin expression in skeletal muscle of mdx mice.
Jason H Williams, Rebecca C Schray, Shashank R Sirsi, Gordon J Lutz

BMC Biotechnol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of dystrophin expression by exon skipping in mdx mice following intramuscular injection of antisense oligonucleotides complexed with PEG-PEI copolymers.
Jason H Williams, Shashank R Sirsi, Daniel R Latta, Gordon J Lutz

Mol Ther· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poly(ethylene imine)-poly(ethylene glycol) copolymers facilitate efficient delivery of antisense oligonucleotides to nuclei of mature muscle cells of mdx mice.
Shashank R Sirsi, Jason H Williams, Gordon J Lutz

Hum Gene Ther· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis